• AMRI Celebrates 30th Anniversary

    Jul 1, 2021, 16:56 by
    Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, celebrates 30 years since its incorporation in Albany, New York.
    Full story
  • Alfa Chemistry Diversifies Supply of Active Pharmaceutical Ingredients for Pharmaceutical Preparation

    Jul 1, 2021, 16:56 by
    Full story
  • Jubilant Biosys and Yale University have announced a research collaboration for multiple programs

    Jul 1, 2021, 16:56 by
    Jubilant Biosys will provide research services to investigators at Yale University working on novel therapeutic targets.
    Full story
  • Protheragen MedAI Offers Comprehensive Solutions for Drug Research and Development, Medical Imaging and Medical Therapy and Research System

    Jul 1, 2021, 16:56 by
    Full story
  • PolyNovo’s NovoSorb® BTM technology featured in a new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions

    Jul 1, 2021, 16:54 by
    PolyNovo, developers of innovative medical devices, has announced that its NovoSorb® BTM technology has been featured in a new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions.
    Full story
  • Bio-Gate and Avicanna complete first phase of development on CBD and Micro Silver BG™ based skin care products for global commercialization

    Jul 1, 2021, 16:54 by
    About Bio-Gate: Bio-Gate AG is one of the world’s leading providers of innovative technologies and customised solutions for health and hygiene. Our aim is to make living together safer and healthier and to improve the well-being of all individuals. Bio-Gate enhances materials and products with its technologies and antimicrobial and antiviral strategies, and, thereby improves the quality of life of people and animals alike. The company specializes in equipping materials and surfaces with antiviral and antimicrobial properties. Bio-Gate AG enhances materials and products, particularly in the field of medical technology, such as the coating of implants or wound dressings. In addition, Bio-Gate technologies are used to provide consumer, industrial and hygiene products, such as paints, coatings, plastics or protective film sprays with antiviral and antimicrobial properties, thus enhancing them in a unique way. Bio-Gate also uses its unique and multi-functional additive MicroSilver BG in dermatology and cosmetics as well as wound care to provide these kind of products with long-lasting antimicrobial, anti-inflammatory and Microbiome friendly properties.
    Full story
  • Stability Screening Meets Tetravalent Bispecifics In Next Generation Collaboration

    Jul 1, 2021, 16:54 by
    Protein Stable, a joint venture between Applied Photophysics and Fluorescence Innovations, has announced a collaboration with F-star Therapeutics, a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm shift in cancer therapy
    Full story
  • Optima Laboratory Resource Management System V2021.1 Software Release Announcement

    Jul 1, 2021, 16:54 by
    Optima, a software company aiming to provide solutions to address laboratory resource management challenges, has announced the new Optima Laboratory Resource Management System — LRMS version 2021.1.
    Full story
  • Nottingham University Hospitals NHS Trust selects Indica Labs to deliver their Digital Pathology Solution with HALO AP®

    Jul 1, 2021, 16:54 by
    Nottingham University Hospitals (NUH) NHS Trust, has announced the selection of Indica Labs, the world’s leading provider of computational pathology software and services, to aid in full digitisation of the pathology workflow.
    Full story
  • The Launch of U-Load Dextramer® with Peptide Receptive MHC I and MHC II Monomers Greatly Expands Flexibility while Ensuring Reliable Sensitivity in Exploring Diversity of Cellular Immune Responses

    Jul 1, 2021, 16:53 by
    Dear Nicole, Immudex ApS, a pioneering life science company spearheading the global adoption of precision immune monitoring, has announced the launch of the new U-Load Dextramer® product line.
    Full story
  • BOC Sciences Provides High-quality Raw Materials to Accelerate mRNA Vaccine Supply

    Jul 1, 2021, 16:53 by
    Full story
  • Shimmer Adopts the V3 Framework to Validate its Verisense® Wearable Sensing Platform for Clinical Trials

    Jul 1, 2021, 16:53 by
    The Verisense IMU (inertial measurement unit) was the first Shimmer sensor validated following the V3 framework championed by the Digital Medicine Society (DiMe).
    Full story
  • Takara Bio enters into a license and supply agreement of RetroNectin® with BioNTech Cell & Gene Therapies GmbH

    Jul 1, 2021, 16:53 by
    Takara Bio Inc. has announced that it has entered into a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech").
    Full story
  • IntegrateRNA Develops Customized CircRNA Pull-down Detection Service to Identify The Interaction Between miRNA/RBP and circRNA

    Jul 1, 2021, 16:53 by
    Full story
  • Microbiosci Releases Optimized Real-time PCR Kits for RNA detection and Gene Sequencing

    Jul 1, 2021, 16:53 by
    Full story
  • Creative Biogene Provides Microbial Sequencing Services and Solutions to Support Sequencing and Bioinformatics Analysis

    Jul 1, 2021, 16:53 by
    Full story
  • BioIVT Acquires Serum, Plasma and Reagent Producer and IVD Manufacturer Valley Biomedical Products & Services

    Jul 1, 2021, 16:53 by
    This transaction will expand BioIVT’s in vitro diagnostic, cell and gene therapy support capabilities.
    Full story
  • Different Surface Nanopattering Techniques are Available Now at Matexcel

    Jul 1, 2021, 16:53 by
    Full story
  • The clinical results of SCO-267 was presented at the Virtual 81st Scientific Sessions - American Diabetes Association: First report on the clinical data of a GPR40 full agonist in the phase 1 trial

    Jul 1, 2021, 16:53 by
    SCOHIA PHARMA, a drug discovery bioventure focusing on the field of lifestyle-related diseases such as cardiovascular, metabolic, and renal diseases has announced the results of a phase 1 clinical trial for SCO-267, an orally bioavailable GPR40 full agonist, at the Virtual 81st Scientific Sessions - American Diabetes Association, June 25-29, 2021.
    Full story
  • Creative Biostructure Enables Exosome Isolation and Purification for Various Samples

    Jul 1, 2021, 16:53 by
    Full story
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146 (current)
  • 147
  • 148
  • 149
  • 150
  • »